Recent Articles

• Roche Advances MS Research with OCREVUS and Fenebrutinib Insights
• ARGAN Secures 'BBB-' Rating From S&P with Stable Outlook
• Atos' Groundbreaking Cybersecurity Partnership with European Commission
• Kesimpta: New Study Results Highlight Efficacy in MS Treatment
• Burning Rock Receives Japanese Approval for New Cancer Diagnostic
• Senator Warren Calls for Investigation on TV Giants' Deals
• Elisa's Innovative Call Blocking Feature Disrupts Phone Scammers
• Artea Bankas Secures ECB Approval for Stock Buyback Initiative
• Totalkredit A/S Releases Comprehensive Debtor Distribution Data
• Essential Data on Nykredit Realkredit A/S Mortgage Bonds
• Implantica's RefluxStop Device Receives Favorable FDA Feedback
• Celebrating Talent and Culture at the Watermelon Festival
• DNO ASA Welcomes New CFO Birgitte Wendelbo Johansen
• Foresight Group Expands Share Buyback Program, Enhances Investments
• Key Changes at Volta Finance: Retirement of Director
• Volta Finance Limited Announces New Dividend for Shareholders
• KBC Group's Insights for Bondholders of KBC IFIMA
• Volta Finance Limited Sees Leadership Transition Ahead
• Youxin Technology Soars After Major Acquisition Announcement
• Strengthening Resilience: Corero and Netceed's Partnership
• Com Laude Acquires Markmonitor to Create Domain Powerhouse
• RF Plasma Generator Market Set for Significant Growth Ahead
• OSE Immunotherapeutics Addresses Recent Voting Rights Correction
• OSB Group PLC Expands Share Buyback Initiative for Growth
• Details of NB Private Equity Partners' Recent Share Buyback
• Akropolis Group Secures Stable BB+ Credit Rating Amid Growth Plans
• Pollo AI Unveils Revolutionary AI Video Generator for Creators
• Chery's LEPAS Revolutionizes Global Mobility with User Summit
• Transforming Xinjiang: A Story of Progress and Resilience
• Understanding Sampo plc’s Recent Share Buyback Achievements
• FLSmidth Expands Share Buy-Back Program With Recent Transactions
• Sanofi Releases Q3 2025 Aide Mémoire for Investors
• GCCL and Frontage Laboratories Join Forces for Clinical Trials
• Gavin Newsom's Strong Stance on Electric Vehicles and GM
• Strategic Partnership Enhances Clinical Research Capacity Globally
• Sanofi Ventures Expands Commitment by $625 Million to Innovate Healthcare
• Micron Technology's Upcoming Memory Innovations and Market Growth
• Sanofi Publishes Q3 2025 Financial Update and Resources
• AFL Group Reports Solid Financial Growth for 2025 Half-Year
• Collaboration Between Lantheus and GE HealthCare for PYLARIFY
• Sanofi Ventures Boosts Capital Commitment for Innovative Biotech
• Acer Integrates Himax's Innovative AI Sensing in New Notebook
• Jasper Therapeutics Faces Class Action Amid Development Challenges
• MotherDuck Expands Into Europe with New Cloud Region
• Understanding the 283% Surge of SHF Holdings Stock
• DDB Capital's Vision for Active Living Community Takes Shape
• DDB Capital's Transformative Housing Project Gains Momentum
• Unlocking Global User Engagement: A New Era for LEPAS
• Key Stocks to Monitor: Micron, Cintas, and More Insights
• Signal AI Secures $165 Million to Elevate Risk Management